← Eichor
Condition: Idiopathic Immune Complex Mediated Glomerulonephritis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Idiopathic Immune Complex Mediated Glomerulonephritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN
Phase 2 · 6 location(s) · Omeros Corporation · NCT06209736Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · 131 location(s) · Novartis Pharmaceuticals · NCT05755386
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.